AI assistant
Sending…
Processa Pharmaceuticals, Inc. — Director's Dealing 2025
Feb 18, 2025
35172_dirs_2025-02-18_446c4380-16d3-4d5e-a820-9ebb1424ac8b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-01-27
Reporting Person: Yorke Justin W (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-29 | Warrants | $0.65 | A | 12400 | Acquired | 2030-01-29 | Common Stock (12400) | Indirect |
| 2025-01-29 | Warrants | $0.65 | A | 6200 | Acquired | 2030-01-29 | Common Stock (6200) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3737 | Direct |
| Common Stock | 12400 | Indirect |
| Common Stock | 31232 | Indirect |
More from Processa Pharmaceuticals, Inc.
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Jan 7
Regulatory Filings
2025
Dec 15
Major Shareholding Notification
2025
Nov 7
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Oct 15